Registry

Launched in 2007 by CVIT (the Japanese Association of Cardiovascular Intervention and Therapeutics) as a platform to register PCI (Percutaneous Coronary Intervention) procedures performed in Japan, the Japanese PCI registry (J-PCI) has now been in operation for 17 years. The initial goal was to establish PCI as a safe treatment for all patients with coronary artery disease in Japan. However, in recent years, the objectives of the J-PCI have diversified. For example, as noted in the design paper, the J-PCI now serves as a platform to provide a common dataset infrastructure for participating institutions to enable continuous quality improvement and offer more accurate datasets for evidence generation, including observational research and registry-based randomized clinical trials (RRCTs).
In addition, the J-PCI plans to foster a collaborative approach with other registries in the US and Europe. Currently, a registry integration initiative is being planned in partnership with the American College of Cardiology (ACC) to promote quality improvement (QI) initiatives aimed at enhancing clinical performance by strengthening post-acute myocardial infarction (MI) protocols. Through these activities, the J-PCI supports CVIT’s mission to advance our understanding of cardiovascular intervention and ensure procedural safety.

Tetsuya Amano, MD. PhD.
Registry Committee Chairman, Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT)